scholarly journals Bone marrow scintigraphy using Technetium-99m antigranulocyte antibody in malignant lymphomas

1999 ◽  
Vol 10 (1) ◽  
pp. 79-86 ◽  
Author(s):  
T. Krause ◽  
N. Eisenmann ◽  
M. Reinhardt ◽  
J. Bathmann ◽  
C. Altehoefer ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Malignant Lymphomas ◽  
Technetium 99M ◽  
Bone Marrow Scintigraphy ◽  
Antigranulocyte Antibody

99Tcm-labelled chimeric human/mouse antigranulocyte antibody bone marrow scintigraphy

1998 ◽  
Vol 19 (5) ◽  
pp. 463-474 ◽  
Author(s):  
T. HIGUCHI ◽  
T. INOUE ◽  
M. SARWAR ◽  
N. ORIUCHI ◽  
M. KARASAWA ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Bone Marrow Scintigraphy ◽  
Antigranulocyte Antibody

Bone Marrow Scintigraphy in Patients Treated with Chemotherapy and/or Radiotherapy

1977 ◽  
Vol 16 (02) ◽  
pp. 86-88
Author(s):  
V. Foltýnová ◽  
E. Vétrovcová ◽  
E. Tichá ◽  
J. Brousil
Keyword(s):  
Bone Marrow ◽  
Hodgkin's Disease ◽  
Hodgkin’S Disease ◽  
Detailed Knowledge ◽  
General State ◽  
Bone Marrow Scintigraphy ◽  
Indium 111

SummaryBone marrow scintigraphy after the application of indium 111 In was compared with the results of bone marrow puncture in 18 patients with Hodgkin's disease treated with radiotherapy and/or chemotherapy. Agreement was found in 85% of the cases. When the results of bone marrow puncture were compared with the general state of haemopoiesis estimated scintigraphically agreement was found in only 65%. Bone marrow scintigraphy gives a more detailed knowledge of the general state of haemopoiesis and serves as a guide for the control of therapy with cytostatics and/or irradiation.

Tc-99m Labelled Anti CD 66 Antigranulocyte Antibody Imaging for Assessment of Bone Marrow Reserve

2005 ◽  
Vol 23 (2) ◽  
pp. 119-122
Author(s):  
Alexander Matthies ◽  
M. Reinhardt ◽  
H. Palmedo ◽  
S. Ezziddin ◽  
B. Abramowski ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Antibody Imaging ◽  
Antigranulocyte Antibody

Expression of Activation-induced Cytidine Deaminase in Malignant Lymphomas Infiltrating the Bone Marrow

2008 ◽  
Vol 16 (6) ◽  
pp. 521-529 ◽  
Author(s):  
Knut Engels ◽  
Berit Jungnickel ◽  
Stephanie Tobollik ◽  
Martin-Leo Hansmann ◽  
Susanne Kriener ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Cytidine Deaminase ◽  
Malignant Lymphomas ◽  
Activation Induced Cytidine Deaminase

Bone Marrow Scintigraphy in Paget's Disease of Bone

1990 ◽  
Vol 31 (2) ◽  
pp. 141-144 ◽  
Author(s):  
Ulf Rudberg ◽  
S.-O. Ahlbäck ◽  
R. Udén
Keyword(s):  
Bone Marrow ◽  
Paget’S Disease ◽  
Paget's Disease ◽  
Paget’S Disease Of Bone ◽  
Paget's Disease Of Bone ◽  
Bone Marrow Scintigraphy

Effects of a Single Dose of Rabbit Anti-mouse Lymphocyte Serum on Tumors Induced in Mice by 7,12-Dimethylbenz (a) anthracene Given at Birth

1972 ◽  
Vol 58 (6) ◽  
pp. 397-408 ◽  
Author(s):  
Carlo D. Baroni ◽  
Pietro Mingazzini ◽  
Paolo Pesando ◽  
Anna Cavallero ◽  
Stefania Uccini ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Single Dose ◽  
Malignant Lymphoma ◽  
Single Injection ◽  
Latency Period ◽  
Skin Tumors ◽  
Rabbit Serum ◽  
Normal Rabbit Serum ◽  
Malignant Lymphomas ◽  
Mouse Lymphocyte

The effects of ALS (anti-lymphocyte serum) and NRS (normal rabbit serum) treatments on the development of malignant lymphoma, lung, subcutaneous and skin tumors induced in mice by 7,12-dimethylbenz (a) anthracene (DMBA) are described. Groups of Charles-River mice, injected at birth with a dose of 100 μg of DMBA, received a single injection of ALS or NRS at the same time as DMBA administration or 10, 20, 30, 40 and 50 days after birth. Incidence, latency, histology and spread of the tumors were studied in all groups. It was found that both ALS and NRS increased tumor incidence and shortened their latency period. Malignant lymphomas were the main tumors whose latency was shortened either by ALS or NRS treatment. In addition ALS treatment apparently increased dissemination of DMBA induced lymphoma in bone marrow.

Sign in / Sign up

Export Citation Format

Share Document